A pilot phase II trial of PSC 833 [valspodar] modulation of multidrug resistance to paclitaxel in the treatment of metastatic carcinoma of the breast
Phase of Trial: Phase II
Latest Information Update: 10 Sep 2005
At a glance
- Drugs Valspodar (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Sep 2005 New trial record.